INT-767

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameINT-767
Drug Alias NameDual FXR/TGR5 agonistsFXR & TGR5 BA-derived backupsINT-767
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled bile acid receptor 1 agonistsBile acid receptor FXR agonists
TargetsBile acid receptor FXRG-protein coupled bile acid receptor 1
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntercept Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntercept Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A